<DOC>
	<DOCNO>NCT00404534</DOCNO>
	<brief_summary>A double-blind clinical trial investigate sub-group functional dyspeptic patient without use NSAID gastric erosion could better evolution dyspeptic symptom Helicobacter eradication placebo control group</brief_summary>
	<brief_title>Helicobacter Eradication Relief Dyspeptic Symptoms</brief_title>
	<detailed_description>Objective : investigate sub-group functional dyspeptic patient without use NSAID gastric erosion could better evolution dyspeptic symptom Helicobacter eradication placebo control group Design : A randomized double-blind placebo control clinical trial Inclusion Criteria : Patients 18 year , Functional dyspepsia accordingly Rome III criterion , Helicobacter pylori infection two diagnostic test Exclusion Criteria : No concordance inform consent ; Pregnant woman breast feed trust anticonceptional method ; Structural gastrointestinal abnormality except gastritis , duodenitis hiatal hernia ; Previous treatment Helicobacter pylorus infection ; Previous surgery esophagus , stomach duodenum ; Hypersensitivity drug study ; Proton pump inhibitor use previous 15 day ; H2-antagonists use previous 07 day ; Antibiotics use previous 30 day ; Patients unable answer study questionnaire ; Alcohol abuse ; Drug use ; Serious comorbidities ; Biliary colic ; Irritable bowel syndrome ; Gastroesophageal Reflux Disease Interventions : amoxicillin , clarythromycin , omeprazole 10 day Control : Placebo Outcomes : Primary : Proportion patient 50 % reduction baseline symptom score measure validated Porto Alegre Dyspeptic Symptoms Questionnaire Secondary : Proportion patient 100 % reduction baseline symptom score measure validated Porto Alegre Dyspeptic Symptoms Questionnaire ; Need rescue medication ; Median difference score group ; Mean SF-36 score evolution group ; Lost productivity measure WPAI group Visits : screening , baseline , 4 , 8 , 12 month Endoscopic evaluation : screening , 12 month Helicobacter detection method : urease , histology ( 3 pathologist ) perform screen 12 month</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Patients 18 year Functional dyspepsia accordingly Rome III criterion Helicobacter pylori infection two diagnostic test No concordance inform consent Pregnant woman breast feed trust anticonceptional method Structural gastrointestinal abnormality except gastritis , duodenitis hiatal hernia Previous treatment Helicobacter pylorus infection Previous surgery esophagus , stomach duodenum Hypersensitivity drug study Proton pump inhibitor use previous 15 day H2antagonists use previous 07 day Antibiotics use previous 30 day Patients unable answer study questionnaires Alcohol abuse Drug use Serious comorbidities Biliary colic Irritable bowel syndrome Gastroesophageal Reflux Disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>functional dyspepsia</keyword>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>Anti-Inflammatory Agents , Non-Steroidal</keyword>
	<keyword>Gastritis</keyword>
</DOC>